SCHEMBL8649132

SCHEMBL8649132

COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)CCc1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.69
CYP1A2 P05177 3/20 0.69
CYP2C9 P11712 3/20 0.69
HIF1A Q16665 3/20 0.69
CYP2D6 P10635 2/20 0.69
NPSR1 Q6W5P4 2/20 0.69
TSHR P16473 2/20 0.69
NFKB1 P19838 2/20 0.69
PLA2G2A P14555 4/20 0.66
PLA2G1B P04054 1/20 0.66
AKR1C3 P42330 7/20 0.64
AKR1C2 P52895 7/20 0.64
AKR1C4 P17516 2/20 0.60
AKR1C1 Q04828 2/20 0.60
PTGS2 P35354 3/20 0.60
MEN1 O00255 2/20 0.60
MAPT P10636 2/20 0.60
PMP22 Q01453 2/20 0.60
KMT2A Q03164 2/20 0.60
KDM4E B2RXH2 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13777343 0.86 MEN1 (0.55) LMNACYP1A2CYP2C9HIF1ACYP2D6
SCHEMBL13777321 0.83 PLA2G2A (0.52) LMNACYP1A2CYP2C9HIF1ACYP2D6
SCHEMBL1082631 0.82 HIF1A (1.00) LMNACYP1A2CYP2C9HIF1ACYP2D6
SCHEMBL5644884 0.82 LMNA (0.77) LMNACYP1A2CYP2C9HIF1ACYP2D6
SCHEMBL10876035 0.81 AKR1C3 (0.76) LMNACYP1A2CYP2C9HIF1ACYP2D6
SCHEMBL5646126 0.81 LMNA (0.76) LMNACYP1A2CYP2C9HIF1ACYP2D6
Hydrochloric Acid SCHEMBL8646699 0.81 HIF1A (0.98) LMNACYP1A2CYP2C9HIF1ACYP2D6
SCHEMBL8648170 0.80 PLA2G2A (0.84) LMNACYP1A2CYP2C9HIF1ACYP2D6
SCHEMBL7963016 0.80 PLA2G2A (1.00) LMNACYP1A2CYP2C9HIF1ANPSR1
SCHEMBL11859825 0.80 LMNA (0.71) LMNACYP1A2CYP2C9HIF1ACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0746544-B1 NOVEL INDOLE DERIVATIVES USEFUL TO TREAT ESTROGEN-RELATED NEOPLASMS AND DISORDERS MERRELL PHARMA INC (US) 1998-09-09 EP disclosed